Quercetin-loaded nanoparticles enhance cytotoxicity and antioxidant activity on C6 glioma cells

References

• Alimohammadi YH, Joo SW. 2014. PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev. 15:517–535.
   PubMedGoogle Scholar
• Alphandéry E. 2018. Glioblastoma treatments: an account of recent industrial developments. Front Pharmacol. 9:879.
   PubMed Web of Science ®Google Scholar
• Arasoglu T, Derman S, Mansuroglu B. 2016. Comparative evaluation of antibacterial activity of caffeic acid phenethyl ester and PLGA nanoparticle formulation by different methods. Nanotechnology. 27(2):025103.
   PubMed Web of Science ®Google Scholar
• Arasoglu T, Derman S, Mansuroglu B, Uzunoglu D, Kocyigit BS, Gumus B, Acar T, Tuncer B. 2017. Preparation, characterization, and enhanced antimicrobial activity: quercetin-loaded PLGA nanoparticles against foodborne pathogens. Turk J Biol. 41(1):127–140.
   Web of Science ®Google Scholar
• Arasoğlu T, Derman S. 2018. Assessment of the antigenotoxic activity of poly (d, l-lactic-co-glycolic acid) nanoparticles loaded with caffeic acid phenethyl ester using the Ames Salmonella/microsome assay. J Agric Food Chem. 66(24):6196–6204.
   PubMed Web of Science ®Google Scholar
• Baran I, Ganea C, Ursu I, Baran V, Calinescu O, Iftime A, Ungureanu R, Tofolean I. 2011. Fluorescence properties of quercetin in human leukemia Jurkat T-cells. Rom J Phys. 56(3-4):388–398.
   Web of Science ®Google Scholar
• Bishayee K, Khuda-Bukhsh AR, Huh S-O. 2015. PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells. Molecules Cells. 38(6):518–527.
   PubMed Web of Science ®Google Scholar
• Bisht R, Rupenthal ID. 2018. PLGA nanoparticles for intravitreal peptide delivery: statistical optimization, characterization and toxicity evaluation. Pharm Dev Technol. 23(4):324–333.
   PubMed Web of Science ®Google Scholar
• Boyne AF, Ellman GL. 1972. A methodology for analysis of tissue sulfhydryl components. Anal Biochem. 46(2):639–653.
   PubMed Web of Science ®Google Scholar
• Braganhol E, Zamin LL, Canedo AD, Horn F, Tamajusuku AS, Wink MR, Salbego C, Battastini AM. 2006. Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anti-Cancer Drugs. 17(6):663–671.
   PubMed Web of Science ®Google Scholar
• Bruning A. 2013. Inhibition of mTOR signaling by quercetin in cancer treatment and prevention. ACAMC. 13(7):1025–1031.
   Google Scholar
• Caffo M, Cardali SM, Fazzari E, Barresi V, Caruso G. 2018. Nanoparticles drug-delivery systems and antiangiogenic approaches in the treatment of gliomas. Glioma. 1(6):183.
   Google Scholar
• Cai X, Fang Z, Dou J, Yu A, Zhai G. 2013. Bioavailability of quercetin: problems and promises. CMC. 20(20):2572–2582.
   PubMed Web of Science ®Google Scholar
• Chahar MK, Sharma N, Dobhal MP, Joshi YC. 2011. Flavonoids: a versatile source of anticancer drugs. Phcog Rev. 5(9):1.
   Google Scholar
• Chuan L, Zhang J, Yu-Jiao Z, Shu-Fang N, Jun C, Qian W, Shao-Ping N, Ze-Yuan D, Ming-Yong, X. 2015. Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals. Chinese J Nat Med. 13(9):641–652.
   PubMed Web of Science ®Google Scholar
• Davis ME. 2016. Glioblastoma: overview of disease and treatment. CJON. 20(5):S2–S8.
   Web of Science ®Google Scholar
• Derman S. 2015. Caffeic acid phenethyl ester loaded PLGA nanoparticles: effect of various process parameters on reaction yield, encapsulation efficiency, and particle size. J Nanomater. 16(1):318.
   Google Scholar
• Duranoğlu D, Uzunoglu D, Mansuroglu B, Arasoglu T, Derman S. 2018. Synthesis of hesperetin-loaded PLGA nanoparticles by two different experimental design methods and biological evaluation of optimized nanoparticles. Nanotechnology. 29(39):395603.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Cheeseman KH. 1990. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Meth Enzymol. 186:407–421.
   PubMed Web of Science ®Google Scholar
• Florence AT, Hillery AM, Hussain N, Jani PU. 1995. Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J Controlled Release. 36(1-2):39–46.
   Web of Science ®Google Scholar
• Gibellini L, Pinti M, Nasi M, De Biasi S, Roat E, Bertoncelli L, Cossarizza A. 2010. Interfering with ROS metabolism in cancer cells: the potential role of quercetin. Cancers. 2(2):1288–1311.
   PubMedGoogle Scholar
• Gibellini L, Pinti M, Nasi M, Montagna JP, De Biasi S, Roat E, Bertoncelli L, Cooper EL, Cossarizza A. 2011. Quercetin and cancer chemoprevention. Evid-Based Complementary Altern Med. 2011:1–15.
   Web of Science ®Google Scholar
• Granato M, Rizzello C, Gilardini Montani MS, Cuomo L, Vitillo M, Santarelli R, Gonnella R, D'Orazi G, Faggioni A, Cirone M. 2017. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways. J Nutr Biochem. 41:124–136.
   PubMed Web of Science ®Google Scholar
• Hans M, Lowman A. 2002. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci. 6(4):319–327.
   Web of Science ®Google Scholar
• Hashemzaei M, Far AD, Yari A, Heravi RE, Tabrizian K, Taghdisi SM, Sadegh SE, Tsarouhas K, Kouretas D, Tzanakakis G, et al. 2017. Anticancer and apoptosis‑inducing effects of quercetin in vitro and in vivo. Oncol Rep. 38(2):819–828.
   PubMed Web of Science ®Google Scholar
• Kajbafvala A, Salabat A, Salimi A. 2018. Formulation, characterization, and in vitro/ex vivo evaluation of quercetin-loaded microemulsion for topical application. Pharm Dev Technol. 23(8):741–750.
   PubMed Web of Science ®Google Scholar
• Khalil NM, do Nascimento TCF, Casa DM, Dalmolin LF, de Mattos AC, Hoss I, Romano MA, Mainardes RM. 2013. Pharmacokinetics of curcumin-loaded PLGA and PLGA–PEG blend nanoparticles after oral administration in rats. Colloids Surf, B. 101:353–360.
   PubMed Web of Science ®Google Scholar
• Khan F, Niaz K, Maqbool F, Ismail Hassan F, Abdollahi M, Nagulapalli Venkata K, Nabavi S, Bishayee A. 2016. Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients. 8(9):529.
   PubMed Web of Science ®Google Scholar
• McCord JM, Fridovich I. 1969. Superoxide dismutase an enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 244(22):6049–6055.
   PubMed Web of Science ®Google Scholar
• Men K, Duan X, Wei Wei X, Ling Gou M, Juan Huang M, Juan Chen L, Yong Qian Z, Quan Wei Y. 2014. Nanoparticle-delivered quercetin for cancer therapy. ACAMC. 14(6):826–832.
   Google Scholar
• Mittal AK, Kumar S, Banerjee UC. 2014. Quercetin and gallic acid mediated synthesis of bimetallic (silver and selenium) nanoparticles and their antitumor and antimicrobial potential. J Colloid Interface Sci. 431:194–199.
   PubMed Web of Science ®Google Scholar
• Mo L, Hou L, Guo D, Xiao X, Mao P, Yang X. 2012. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Int J Pharm. 436(1-2):815–824.
   PubMedGoogle Scholar
• Morry J, Ngamcherdtrakul W, Yantasee W. 2017. Oxidative stress in cancer and fibrosis: opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles. Redox Biol. 11:240–253.
   PubMed Web of Science ®Google Scholar
• Mudshinge SR, Deore AB, Patil S, Bhalgat CM. 2011. Nanoparticles: emerging carriers for drug delivery. Saudi Pharmaceu J. 19(3):129–141.
   PubMed Web of Science ®Google Scholar
• Nguyen LT, Lee YH, Sharma AR, Park JB, Jagga S, Sharma G, Lee SS, Nam JS. 2017. Quercetin induces apoptosis and cell cycle arrest in triple-negative breast cancer cells through modulation of Foxo3a activity. Korean J Physiol Pharmacol. 21(2):205–213.
   PubMed Web of Science ®Google Scholar
• Ozgen S, Kilinc OK, Selamoğlu Z. 2016. Antioxidant activity of quercetin: a mechanistic review. Turkish Jaf Scitech. 4(12):1134–1138.
   Google Scholar
• Pimple S, Manjappa AS, Ukawala M, Murthy R. 2012. PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy. Cancer Nano. 3(1-6):25–36.
   PubMedGoogle Scholar
• Priyadarsini RV, Murugan RS, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S. 2010. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur J Pharmacol. 649(1-3):84–91.
   PubMed Web of Science ®Google Scholar
• Rezvantalab S, Drude NI, Moraveji MK, Güvener N, Koons EK, Shi Y, Lammers T, Kiessling F. 2018. PLGA-based nanoparticles in cancer treatment. Front Pharmacol. 9:1260.
   PubMed Web of Science ®Google Scholar
• Rizvi SA, Saleh AM. 2018. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. 26(1):64–70.
   PubMed Web of Science ®Google Scholar
• Russo GL, Russo M, Spagnuolo C, Tedesco I, Bilotto S, Iannitti R, Palumbo R. 2014. Quercetin: a pleiotropic kinase inhibitor against cancer. In: Zappia V, Panico S, Russo G, Budillon A, Della Ragione F, editors. Advances in nutrition and cancer. Berlin: Springer; p. 185–205.
   Google Scholar
• Shafabakhsh R, Asemi Z. 2019. Quercetin: a natural compound for ovarian cancer treatment. J Ovarian Res. 12(1):55.
   PubMedGoogle Scholar
• Singh R, Lillard JW. 2009. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 86(3):215–223.
   PubMed Web of Science ®Google Scholar
• Smith AJ, Kavuru P, Wojtas L, Zaworotko MJ, Shytle RD. 2011. Cocrystals of quercetin with improved solubility and oral bioavailability. Mol Pharmaceutics. 8(5):1867–1876.
   PubMed Web of Science ®Google Scholar
• Souto EB, Severino P, Basso R, Santana MHA. 2013. Encapsulation of antioxidants in gastrointestinal-resistant nanoparticulate carriers. In: Armstrong D, Bharali D, editors. Oxidative stress and nanotechnology. Totowa (NJ): Humana Press; p. 37–46.
   Google Scholar
• Sun H, Xu H, Yang X, Li N, Liu Z, Pan W, Yuan Y. 2011. Formulation of a stable and high-loaded quercetin injectable emulsion. Pharm Dev Technol. 16(6):609–615.
   PubMed Web of Science ®Google Scholar
• Van Tellingen O, Yetkin-Arik B, De Gooijer M, Wesseling P, Wurdinger T, De Vries H. 2015. Overcoming the blood–brain tumor barrier for effective glioblastoma treatment. Drug Resistance Updates. 19:1–12.
   PubMed Web of Science ®Google Scholar
• Walker JM. 2002. The bicinchoninic acid (BCA) assay for protein quantitation. In: Walker JM, editor. The protein protocols handbook. Totowa (NJ): Humana Press; p. 11–14.
   Google Scholar
• Wang H-K. 2000. The therapeutic potential of flavonoids. Expert Opin Invest Drugs. 9(9):2103–2119.
   PubMed Web of Science ®Google Scholar
• Wu TH, Yen FL, Lin LT, Tsai TR, Lin CC, Cham TM. 2008. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. Int J Pharm. 346(1-2):160–168.
   PubMed Web of Science ®Google Scholar
• Zhang M, Swarts SG, Yin L, Liu C, Tian Y, Cao Y, Swarts M, Yang S, Zhang SB, Zhang K. 2011. Antioxidant properties of quercetin. In: LaManna J, Puchowicz M, Xu K, Harrison D, Bruley D. Oxygen transport to tissue XXXII. Boston (MA): Springer; p. 283–289.
   Google Scholar
• Zhishen J, Mengcheng T, Jianming W. 1999. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem. 64(4):555–559.
   Web of Science ®Google Scholar